Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nanobiotix S.A. - ADSs
(NQ:
NBTX
)
34.59
-0.67 (-1.90%)
Streaming Delayed Price
Updated: 1:23 PM EDT, Sep 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
66,462
Open
34.64
Bid (Size)
34.46 (100)
Ask (Size)
34.63 (100)
Prev. Close
35.26
Today's Range
33.82 - 35.34
52wk Range
9.320 - 57.14
Shares Outstanding
34,432,122
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer
September 14, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 09, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Performance
YTD
+56.3%
+56.3%
1 Month
-17.7%
-17.7%
3 Month
-3.9%
-3.9%
6 Month
+7.8%
+7.8%
1 Year
+271.1%
+271.1%
More News
Read More
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.
↗
August 31, 2026
Via
The Motley Fool
Voting Rights and Shares Capital of the Company
August 25, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
July 30, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
June 05, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Provides First Quarter 2026 Operational and Financial Update
June 02, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Joins the Euronext Tech Leaders Index
June 02, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Announces Closing of Global Offering
May 26, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
May 22, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
May 21, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
May 21, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
May 21, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Launch of Global Follow-On Offering
May 20, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
May 17, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
May 04, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
April 20, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
April 07, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
March 31, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
March 30, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026
March 26, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Statement Regarding Recent Media Speculation
March 25, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
March 12, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Participate in Investor Conferences in March
February 25, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
February 17, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Frequently Asked Questions
Is Nanobiotix S.A. - ADSs publicly traded?
Yes, Nanobiotix S.A. - ADSs is publicly traded.
What exchange does Nanobiotix S.A. - ADSs trade on?
Nanobiotix S.A. - ADSs trades on the Nasdaq Stock Market
What is the ticker symbol for Nanobiotix S.A. - ADSs?
The ticker symbol for Nanobiotix S.A. - ADSs is NBTX on the Nasdaq Stock Market
What is the current price of Nanobiotix S.A. - ADSs?
The current price of Nanobiotix S.A. - ADSs is 34.59
When was Nanobiotix S.A. - ADSs last traded?
The last trade of Nanobiotix S.A. - ADSs was at 09/16/26 01:23 PM ET
What is the market capitalization of Nanobiotix S.A. - ADSs?
The market capitalization of Nanobiotix S.A. - ADSs is 1.19B
How many shares of Nanobiotix S.A. - ADSs are outstanding?
Nanobiotix S.A. - ADSs has 1B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
